US BROKER MOVES: PLD upgraded at Raymond James; MBLY downgraded at RBC
Newsquawk Staff ·
UPGRADES
- Clean Harbors (CLH) Upgraded from Neutral to Buy at UBS; PT USD 375
- Compass (COMP) Upgraded from Hold to Buy at Zelman & Associates
- DigitalOcean (DOCN) Upgraded from Neutral to Overweight at Piper Sandler; PT USD 126
- Fifth Third Bancorp (FITB) Upgraded from In Line to Outperform at Evercore ISI
- Intuitive Surgical (ISRG) Upgraded from Hold to Buy at Erste Group
- Blue Owl Technology Finance (OTF) Upgraded from Hold to Buy at Clear Street; PT USD 12
- Prologis (PLD) Upgraded from Market Perform to Outperform at Raymond James; PT USD 163
- Runway Growth Finance (RWAY) Upgraded from Hold to Buy at Clear Street; PT USD 7.50
- Transcat (TRNS) Upgraded from Market Perform to Outperform at Northland; PT USD 95
- Zoom Communications (ZM) Upgraded from Perform to Outperform at Oppenheimer; PT USD 130
DOWNGRADES
- Ally Financial (ALLY) Downgraded from Outperform to Underperform at Evercore ISI; PT USD 40
- Braze (BRZE) Downgraded from Buy to Hold at TD Cowen; PT USD 47.50
- Braze (BRZE) Downgraded from Outperform to Market Perform at Raymond James
- Braze (BRZE) Downgraded from Outperform to Neutral at Mizuho; PT USD 47.50
- Braze (BRZE) Downgraded from Overweight to Equal Weight at Stephens
- Chipotle Mexican Grill (CMG) Downgraded from Buy to Hold at TD Cowen; PT USD 32
- Casella Waste Systems (CWST) Downgraded from Buy to Neutral at UBS; PT USD 95
- Fortinet (FTNT) Downgraded from Buy to Sell at Arete; PT USD 117
- Johnson & Johnson (JNJ) Downgraded from Buy to Hold at Erste Group
- Mobileye (MBLY) Downgraded from Sector Perform to Underperform at RBC Capital; PT USD 5
- Moody's (MCO) Downgraded from Overweight to Neutral at Huber Research
- Netflix (NFLX) Downgraded from Buy to Hold at Needham
- The Real Brokerage (REAX) Downgraded from Outperform to Neutral at Zelman & Associates
- Silence Therapeutics (SLN) Downgraded from Buy to Neutral at H.C. Wainwright
- SmartFinancial (SMBK) Downgraded from Strong Buy to Outperform at Raymond James; PT USD 56
- Synchrony Financial (SYF) Downgraded from Outperform to In Line at Evercore ISI; PT USD 78
INITIATIONS
- AIR Global (AIIR) Initiated at Buy at Roth/MKM; PT USD 11.50
- Amphenol (APH) Initiated at Buy at Erste Group
- Applied Digital (APLD) Initiated at Buy at Roth/MKM; PT USD 35
- Chilwa Minerals (CHWM) Initiated at Buy at Maxim Group; PT USD 11
- CytoSorbents (CTSO) Initiated at Speculative Buy at WBB Securities; PT USD 9.50
- eBay (EBAY) Initiated at Buy at Erste Group
- Robinhood (HOOD) Initiated at Buy at Rosenblatt; PT USD 135
- Terrestrial Energy (IMSR) Initiated at Buy at Lake Street; PT USD 15
- Kazia Therapeutics (KZIA) Initiated at Buy at Guggenheim; PT USD 35
- QumulusAI (QMLS) Initiated at Buy at B. Riley; PT USD 11
- Vor Biopharma (VOR) Initiated at Outperform at William Blair
- Xilio Therapeutics (XLO) Initiated at Outperform at Raymond James; PT USD 16
What it means
Bulk broker roundups of this kind are a routine open-of-session fixture; the signal is rarely in any single rating but in the clustering, and here the standout pattern is Braze drawing four simultaneous downgrades across TD Cowen, Raymond James, Mizuho and Stephens, a configuration that in past episodes of this kind has pointed to a shared post-print reassessment of guidance rather than independent conviction, and which tends to gap the name more durably than a lone call. Evercore ISI's paired move, upgrading Fifth Third while cutting Ally and Synchrony, reads as a relative-value rotation within consumer and regional credit rather than a sector call, the kind of switch that has historically moved spreads between the peer set more than the group outright. The RBC cut on Mobileye to an underperform with a low single-digit target sits in the established pattern of autonomous-driving names de-rating on volume and competition concerns, a call type that has tended to find follow-through when peers echo it. Single-shop calls on the liquid large caps, Needham on Netflix, Raymond James on Prologis, have historically faded within sessions absent corroboration. Worth noting is whether any of the clustered downgrades are tied to a recent earnings print, since clustered post-print cuts have tended to mark short-term sentiment floors or acceleration points depending on positioning.
- US PRE-MARKET MOVERS: SMCI, NFLX, SPCX, UAL, T, COF, MCO, PM, ABT
- [CALENDAR ADDITION] Nvidia (NVDA) CEO to deliver a keynote speech at the GTC Summit at 10:00BST/05:00EDT
- Newsquawk Daily European Opening News - 21st October 2026
- [MARKET ANALYSIS] USD marginally firmer; AUD outperforms; price action quiet elsewhere
- TREASURY WRAP: T-NOTE FUTURES (Z6) SETTLED 2 TICKS HIGHER AT 105-10
Related headlines
- Hims (HIMS) expands testosterone care with injectable and oral TRT, its largest men’s health launch to date28 min ago
- [Rolling headline]: Nvidia (NVDA) CEO delivering a keynote speech and has announced a raft of partnerships38 min ago
- Google (GOOGL) launches OpenAI models through its cloud39 min ago
- eBay (EBAY) reportedly cutting 9% of workforce to simplify operations and prioritise growth areas59 min ago
- Iren (IREN) is to advance Europe's sovereign AI ambitions with 300mw Spanish campus1 hour ago
- NextEra Energy Inc. (NEE) Q3 2026 (USD): Adj. EPS 1.24 (exp. 1.18), Adj. net income 2.59bln (exp. 2.43bln)1 hour ago
- CrowdStrike (CRWD) and Nvidia (NVDA) expand AI agent security to silicon; By 2028, production for Nvidia to account for significant portion of annual substrate capacity1 hour ago
- Abbott Laboratories (ABT) Q3 2026 (USD): Adj. EPS 1.42 (exp. 1.42), Revenue 13.0bln (exp. 12.99bln)1 hour ago
- Abbott (ABT) announced its intention to separate its Nutrition business into an independent, publicly traded company with approximately USD 8.5bln in annual sales and a portfolio of brands1 hour ago
- CME Group Inc. (CME) Q3 2026 (USD): Adj. EPS 3.02 (exp. 2.98), Revenue 1.7bln (exp. 1.71bln)1 hour ago
- Moody's (MCO) Q3 2026 (USD): Adj. EPS 4.14 (exp. 4.24), Revenue 2.023bln (exp. 2.07bln)1 hour ago
- Philip Morris International Inc. (PM) Q3 2026 (USD): Adj. EPS 2.36 (exp. 2.29), Net revenue 11.4bln (exp. 11.32bln)1 hour ago
- Oracle (ORCL) launches an AI agent studio for industry applications1 hour ago
- European Commision has improved Merck's (MRK) Keytruda plus Padcev, as perioperative treatment2 hours ago
- NVIDIA (NVDA) and Supply Chain Partners expand capacity to accelerate AI infrastructure buildout2 hours ago